A phase III trial of empiric chemotherapy with cisplatin and gemcitabine or systemic treatment tailored by molecular gene expression analysis in patients with carcinomas of an unknown primary (CUP) site (GEFCAPI 04)
K. Fizazi, A. Maillard, N. Penel, G. Baciarello, D. Allouache, et al.. A phase III trial of empiric chemotherapy with cisplatin and gemcitabine or systemic treatment tailored by molecular gene expression analysis in patients with carcinomas of an unknown primary (CUP) site (GEFCAPI 04). Annals of Oncology, 2019, 30 (5), pp.851. ⟨10.1093/annonc/mdz394⟩. ⟨hal-03598661⟩